News
AEON
0.2600
+3.71%
0.0093
Weekly Report: what happened at AEON last week (0720-0724)?
Weekly Report · 1d ago
AEON Biopharma boosts liquidity with additional share sale
TipRanks · 4d ago
Weekly Report: what happened at AEON last week (0713-0717)?
Weekly Report · 07/20 09:58
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 07/15 17:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 07/15 12:05
Why Aehr Test Systems Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Benzinga · 07/15 08:32
AEON Biopharma Prices Upsized Public Offering With Potential Gross Proceeds Of Up To $43.3 Mln
NASDAQ · 07/14 14:38
Aeon announces pricing of upsized $13.75M public offering
TipRanks · 07/14 14:15
AEON Biopharma prices $13.75M offering with milestone warrants
Seeking Alpha · 07/14 12:32
Why Vision Marine Technologies Shares Are Trading Higher By Over 60%; Here Are 20 Stocks Moving Premarket
Benzinga · 07/14 08:56
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
Barchart · 07/14 07:00
Weekly Report: what happened at AEON last week (0706-0710)?
Weekly Report · 07/13 10:00
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga · 07/09 17:05
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/09 12:05
*AEON Biopharma Offering 17.5M Shrs or Pre-Funded Warrants Along With Two-Year and Five-Year Milestone Warrants
Dow Jones · 07/08 21:29
Weekly Report: what happened at AEON last week (0629-0703)?
Weekly Report · 07/06 10:03
Weekly Report: what happened at AEON last week (0622-0626)?
Weekly Report · 06/29 09:59
Weekly Report: what happened at AEON last week (0615-0619)?
Weekly Report · 06/22 10:06
AEON Biopharma shareholders approve directors and auditor slate
TipRanks · 06/17 21:36
Weekly Report: what happened at AEON last week (0608-0612)?
Weekly Report · 06/15 10:07
More
Webull provides a variety of real-time AEON stock news. You can receive the latest news about Aeon Biopharma through multiple platforms. This information may help you make smarter investment decisions.
About AEON
AEON Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing its botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection or ABP-450, for debilitating medical conditions, with an initial focus on the neuroscience market. ABP-450 is a 2-chain polypeptide, a heavy chain joined by a bond to a light chain. ABP-450 interferes with nerve impulses by inhibiting the release of acetylcholine into the neuromuscular junction, causing a flaccid paralysis of muscles. The active biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a complete molecular complex weight of 900 kDa. Its initial development programs for ABP-450 are directed at migraine, cervical dystonia, gastroparesis and post-traumatic stress disorder (PTSD). The Company has completed enrollment and dosing of patients for a Phase II double blind study of ABP-450 for the treatment of both chronic and episodic migraine.